Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1. [electronic resource]
Producer: 20120731Description: 487-92 p. digitalISSN:- 1573-2584
- Aged
- Aged, 80 and over
- Androgen Antagonists -- administration & dosage
- Biopsy
- Disease Progression
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Endosonography
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.